Outcomes |  | peginterferon beta-1a 125 μg | IFN beta-1b 250 μga | IFN beta-1a 250 μgb | GA 20 mg |
---|---|---|---|---|---|
Clinical outs. | LYs | 19.94 | 19.68 | 19.68 | 19.68 |
 | QALYs | 9.07 | 8.06 | 8.06 | 8.15 |
[a] | Â | Â | 1.01 | 1.01 | 0.92 |
Cost outs. (€) | Drugs & mon. | 113,095 | 92,105 | 86,019 | 82,887 |
 | Relapses | 8789 | 8808 | 8808 | 8502 |
 | Adverse events | 102 | 110 | 110 | 94 |
 | Disease manag. | 111,107 | 121,277 | 121,277 | 121,424 |
 | Total cost | 233,091 | 222,399 | 216,213 | 212,908 |
[b] | Â | Â | 10,691 | 16,877 | 20,183 |
ICER (€) [c] |  |  | 10,580 | 16,702 | 22,023 |